Title
Erratum: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients (PLoS ONE (2020) 15:11 (e0242184) DOI: 10.1371/journal.pone.0242184)
Date Issued
01 May 2022
Access level
open access
Resource Type
corrigendum
Author(s)
Camprubí D.
Almuedo-Riera A.
Martí-Soler H.
Soriano A.
Subirà C.
Grau-Pujol B.
Krolewiecki A.
Muñoz J.
Publisher(s)
Public Library of Science
Abstract
In the Results section, there is an error in the sixth sentence of the second paragraph. The correct sentence is: Although no statistically significant differences in baseline characteristics were observed between groups, 38% of patients in the IVM group and 69% in the non-IVM group were initially admitted to an intensive care unit (ICU) (p = 0.238) (Table 1). It is noted that a non-significant result does not confirm the absence of an effect. Therefore, the authors provide the following corrections to errors in the title, and in the Discussion section, in the first sentence of the first paragraph. The correct title of the manuscript is: Lack of evidence for efficacy of standard doses of ivermectin in severe COVID-19 patients. The correct citation is: Camprubí D, Almuedo-Riera A, Martí-Soler H, Soriano A, Hurtado JC, Subirà C, et al. (2020) Lack of evidence for efficacy of standard doses of ivermectin in severe COVID-19 patients. PLoS ONE 15(11): e0242184. https://doi.org/10.1371/journal.pone.0242184 In the Discussion section, in the first sentence of the first paragraph, the correct sentence is: In our retrospective study, we did not observe significant differences in clinical and microbiological outcomes of patients with severe COVID-19 receiving a single dose of 200 μg/kg of IVM compared to a similar group of patients not receiving the drug.
Volume
17
Issue
5 May
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Sistema respiratorio
Scopus EID
2-s2.0-85130636228
PubMed ID
Source
PLoS ONE
ISSN of the container
19326203
Sources of information:
Directorio de Producción Científica
Scopus